These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27349839)

  • 1. Comparison of different collection methods for reported adverse events following pandemic and seasonal influenza vaccination.
    Kemmeren J; Honsbeek M; Dijkstra F; de Lange M; van der Maas N; Smallenburg R; Koppeschaar C; van der Hoek W
    Vaccine; 2016 Jul; 34(34):3961-6. PubMed ID: 27349839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability of 2 doses of pandemic influenza vaccine (Focetria®) and of a prior dose of seasonal 2009-2010 influenza vaccination in the Netherlands.
    van der Maas NA; Godefrooij S; Vermeer-de Bondt PE; de Melker HE; Kemmeren J
    Hum Vaccin Immunother; 2016 Apr; 12(4):1027-32. PubMed ID: 26809939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring adverse events of the vaccination campaign against influenza A (H1N1) in the Netherlands.
    van Puijenbroek EP; Broos N; van Grootheest K
    Drug Saf; 2010 Dec; 33(12):1097-108. PubMed ID: 21077700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the feasibility and usability of a proof of concept mobile app for adverse event reporting post influenza vaccination.
    Wilson K; Atkinson KM; Westeinde J; Bell C; Marty K; Fergusson D; Deeks SL; Crowcroft N; Bettinger JA
    Hum Vaccin Immunother; 2016 Jul; 12(7):1738-48. PubMed ID: 26905396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fever following immunization with influenza A (H1N1) vaccine in children: a survey-based study in the Netherlands.
    Broos N; van Puijenbroek EP; van Grootheest K
    Drug Saf; 2010 Dec; 33(12):1109-15. PubMed ID: 21077701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Attitudes and side effects related to pandemic influenza A (H1N1) vaccination in healthcare personnel].
    Ormen B; Türker N; Vardar I; Kaptan F; El S; Ural S; Kaya F; Coşkun NA
    Mikrobiyol Bul; 2012 Jan; 46(1):57-64. PubMed ID: 22399172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Web-based intensive monitoring of adverse events following influenza vaccination in general practice.
    van Balveren-Slingerland L; Kant A; Härmark L
    Vaccine; 2015 May; 33(19):2283-2288. PubMed ID: 25797367
    [No Abstract]   [Full Text] [Related]  

  • 8. [Variability in the reporting of adverse reactions to the pandemic and seasonal influenza vaccine: seasons 2009-2010 and 2010-2011. Valencian community, Spain].
    Alguacil Ramos AM; Lluch Rodrigo JA; Portero Alonso A; Martín Ivorra R; Pastor Villalba E
    Rev Esp Salud Publica; 2012; 86(3):241-51. PubMed ID: 22991081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2017/18 and 2018/19 seasonal influenza vaccine safety surveillance, Canadian National Vaccine Safety (CANVAS) Network.
    Bettinger JA; De Serres G; Valiquette L; Vanderkooi OG; Kellner JD; Coleman BL; Top KA; Isenor JE; McCarthy AE;
    Euro Surveill; 2020 Jun; 25(22):. PubMed ID: 32524947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex and gender differences in adverse events following influenza and COVID-19 vaccination.
    Yin A; Wang N; Shea PJ; Rosser EN; Kuo H; Shapiro JR; Fenstermacher KZJ; Pekosz A; Rothman RE; Klein SL; Morgan R
    Biol Sex Differ; 2024 Jun; 15(1):50. PubMed ID: 38890702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of response rates on invitation mode of a web-based survey on influenza vaccine adverse events among healthcare workers: a pilot study.
    Tai X; Smith AM; McGeer AJ; Dubé E; Holness DL; Katz K; McGillis Hall L; McNeil SA; Powis J; Coleman BL
    BMC Med Res Methodol; 2018 Jun; 18(1):59. PubMed ID: 29925324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial.
    Vajo Z; Tamas F; Sinka L; Jankovics I
    Lancet; 2010 Jan; 375(9708):49-55. PubMed ID: 20018367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvanted A/H1N1 (2009) influenza vaccination during pregnancy: description of a prospective cohort and spontaneously reported pregnancy-related adverse reactions in the Netherlands.
    de Vries L; van Hunsel F; Cuppers-Maarschalkerweerd B; van Puijenbroek E; van Grootheest K
    Birth Defects Res A Clin Mol Teratol; 2014 Oct; 100(10):731-8. PubMed ID: 24706475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination Against Seasonal or Pandemic Influenza in Emergency Medical Services.
    Moser A; Mabire C; Hugli O; Dorribo V; Zanetti G; Lazor-Blanchet C; Carron PN
    Prehosp Disaster Med; 2016 Apr; 31(2):155-62. PubMed ID: 26857404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceptability of Internet adverse event self-reporting for pandemic and seasonal influenza immunization among health care workers.
    Lapphra K; Dobson S; Bettinger JA
    Vaccine; 2010 Aug; 28(38):6199-202. PubMed ID: 20654668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active surveillance of adverse events following immunization against pandemic influenza A (H1N1) in Korea.
    Choe YJ; Cho H; Song KM; Kim JH; Han OP; Kwon YH; Bae GR; Lee HJ; Lee JK
    Jpn J Infect Dis; 2011; 64(4):297-303. PubMed ID: 21788704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pandemic influenza A (H1N1)v vaccination status and factors affecting vaccination: Ankara and Diyarbakır 2009 data from Turkey].
    Ertek M; Sevencan F; Kalaycıoğlu H; Gözalan A; Simşek C; Culha G; Dorman V; Ozlü A; Arıkan F; Aktaş D; Akın L; Korukluoğlu G; Sevindi DF
    Mikrobiyol Bul; 2011 Oct; 45(4):684-96. PubMed ID: 22090299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced passive surveillance of influenza vaccination in England, 2016-2017- an observational study using an adverse events reporting card.
    de Lusignan S; Ferreira F; Damaso S; Byford R; Pathirannehelage S; Yeakey A; Yonova I; Schuind A; Dos Santos G
    Hum Vaccin Immunother; 2019; 15(5):1048-1059. PubMed ID: 30648923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-authorisation passive enhanced safety surveillance of seasonal influenza vaccines: protocol of a pilot study in England.
    de Lusignan S; Dos Santos G; Correa A; Haguinet F; Yonova I; Lair F; Byford R; Ferreira F; Stuttard K; Chan T
    BMJ Open; 2017 May; 7(5):e015469. PubMed ID: 28515198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring adverse events of vaccines against Mexican flu.
    van Puijenbroek EP; van Grootheest AC
    Int J Risk Saf Med; 2011; 23(2):81-7. PubMed ID: 21673415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.